摘要 |
Methods of treating or managing specific cancers, including non-Hodgkin's lymphoma, by the administration of 3-(4-amino-l-oxo-l,3-dihydro-isoindol-2-yl)- piperidine-2,6-dione are disclosed. Methods of using gene and protein biomarkers as a predictor of non-Hodgkin's lymphoma response to treatment with 3-(4-amino-l-oxo-l,3- dihydro-isoindol-2-yl)-piperidine-2,6-dione are also disclosed. |
申请人 |
CELGENE CORPORATION;SCHAFER, PETER, H.;ZHANG, LING-HUA;BARTLETT, J., BLAKE;HEISE, CARLA |
发明人 |
SCHAFER, PETER, H.;ZHANG, LING-HUA;BARTLETT, J., BLAKE;HEISE, CARLA |